Many of the transgenic AD models exhibit Aβ aggregates, neuronal loss, gliosis and Tau pathology, associated with cognitive impairments, but no single AD model recapitulates full spectrum of AD pathology [35]. Here, MAPT is linked to Alzheimer disease.